LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

2.63 -1.5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.55

Max

2.66

Schlüsselkennzahlen

By Trading Economics

Einkommen

30M

-21M

Verkäufe

35M

480M

Gewinnspanne

-4.351

Angestellte

4,500

EBITDA

512K

15M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+196.7% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

24. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-463M

317M

Vorheriger Eröffnungskurs

4.13

Vorheriger Schlusskurs

2.63

Nachrichtenstimmung

By Acuity

43%

57%

131 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Feb. 2026, 23:57 UTC

Heiße Aktien

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12. Feb. 2026, 23:35 UTC

Ergebnisse
Wichtige Markttreiber

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12. Feb. 2026, 23:28 UTC

Ergebnisse

Applied Materials Profit Rises on Soaring AI Demand -- Update

12. Feb. 2026, 21:47 UTC

Ergebnisse

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13. Feb. 2026, 00:00 UTC

Market Talk

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12. Feb. 2026, 23:47 UTC

Market Talk

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12. Feb. 2026, 23:38 UTC

Market Talk

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12. Feb. 2026, 23:33 UTC

Ergebnisse

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12. Feb. 2026, 23:09 UTC

Market Talk

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12. Feb. 2026, 22:55 UTC

Ergebnisse
Heiße Aktien

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12. Feb. 2026, 22:46 UTC

Market Talk

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12. Feb. 2026, 22:23 UTC

Ergebnisse

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12. Feb. 2026, 22:00 UTC

Ergebnisse

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12. Feb. 2026, 22:00 UTC

Ergebnisse

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12. Feb. 2026, 21:57 UTC

Ergebnisse

XP 4Q Rev BRL4.95B >XP

12. Feb. 2026, 21:52 UTC

Ergebnisse

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

12. Feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. Feb. 2026, 21:47 UTC

Ergebnisse

Morningstar 4Q Rev $641M >MORN

12. Feb. 2026, 21:39 UTC

Ergebnisse

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12. Feb. 2026, 21:38 UTC

Ergebnisse

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

196.7% Vorteil

12-Monats-Prognose

Durchschnitt 8.1 USD  196.7%

Hoch 12 USD

Tief 5 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

11

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

131 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat